Home > Income Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹1,036 Cr₹928 Cr₹590 Cr₹611 Cr₹1,695 Cr

What is the latest Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹1,036 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹1,036 Cr
Mar2025₹928 Cr
Mar2024₹590 Cr
Mar2023₹611 Cr
Mar2022₹1,695 Cr

How is Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹1,036 Cr
11.69
Mar2025 ₹928 Cr
57.23
Mar2024 ₹590 Cr
-3.39
Mar2023 ₹611 Cr
-63.97
Mar2022 ₹1,695 Cr -

Compare Consolidated Net Profit of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹49,915.4 Cr -1.1% 12.7% 9.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹463,791.0 Cr 1.6% -1% 22.2% Stock Analytics
DIVIS LABORATORIES ₹245,081.0 Cr 1.7% 10.1% 49.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,351.0 Cr 1.5% -1.2% 38.2% Stock Analytics
CIPLA ₹114,163.0 Cr 0.7% -3.5% -10.4% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.3 Cr -1.3% 0.1% -7.8% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-1.1%

12.7%

9.5%

SENSEX

-1.2%

-2.6%

-5.2%


You may also like the below Video Courses